TrialBMC research notes2023

Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial.

Alejandro Llanos-Cuentas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.